Mesoblast, A Global Leader in Regenerative Medicine
Mesoblast was founded to bring regenerative medicine therapies to patients with significant unmet needs. To that end, Mesoblast is conducting clinical and preclinical programs in multiple disease states in order to explore the potential of our technology. It is our mission to develop products that will have a meaningful impact on patients. Mesoblast is committed to conducting our research activities in a robust and scientific manner with the goal of improving patient care and providing patients new therapeutic options for their unmet medical needs.
Learn more about Mesoblast, the Sponsor of the DREAM HF-1 Clinical Trial. For more information: